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Abstract We previously reported that endothelin-1 or platelet-
derived growth factor promoted in aortic smooth muscle cells a
rapid hydrolysis of 1-O-alkyl-2-acyl-sn-glycero-3-phospho-
ethanolamine (alkyl-PE) which was immediately converted into
1-O-alkyl-2,3-diacyl-sn-glycerol (alkyl-TG) within 5 s or 60 s
respectively [C. Comminges et al. (1996) Biochem. Biophys. Res.
Commun. 220, 1008^1013 and C. Comminges et al. (1997)
Biochim. Biophys. Acta 1355, 69^80]. In this study, we show that
this alkyl-PE hydrolysis is triggered by a transient activation of a
specific phospholipase C (PLC) regulated by pertussis toxin-
sensitive heterotrimeric G-proteins. Moreover, this PLC can be
triggered through a Ca2+ influx depending on L-type Ca2+
channel activation, as suggested by the use of a specific
‘activator’ S(3)-BayK 8644 and of selective inhibitors such as
nimodipine. Interestingly, low concentrations (1038^1037M) of
alkyl-TG block the opening of L-type Ca2+ channels, whereas
identical concentrations of DG do not alter L-type Ca2+
channels. This study thus unravels a hitherto unrecognized
signaling pathway generating alkyl-TG as a novel lipid second
messenger, potentially acting as a negative feedback regulator of
L-type Ca2+ channels.
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1. Introduction
Since the pioneering study of Nishizuka’s group [1] describ-
ing diacylglycerol as a speci¢c activator of protein kinase C,
the last 20 years have seen the emergence of a number of
intracellular lipid messengers able to modulate the activity
of di¡erent targets involved in cell signaling. Generation of
these second messengers involves a complex set of intracellu-
lar enzymes.
In previous studies, we observed that endothelin-1 (ET-1)
or platelet-derived growth factor (PDGF-BB) induced a very
rapid conversion of 1-O-alkyl-2-acyl-sn-glycero-3-phospho-
ethanolamine (alkyl-PE) into 1-O-alkyl-2,3-diacyl-sn-glycerol
(alkyl-TG) in pig aortic smooth muscle cells (SMC) [2,3].
Although TG are essentially known for their role in fatty
acid storage, their very transient accumulation suggested
that we were dealing with a novel signaling pathway, possibly
involving alkyl-TG as a new intracellular lipid messenger.
This e¡ect did not appear to be restricted to SMC signaling
because a similar response was also obtained with RAW 264.7
macrophage-like cells stimulated by silica (unpublished re-
sults). The simplest pathway to explain the conversion of al-
kyl-PE into alkyl-TG would involve the removal of the phos-
phoethanolamine group by a speci¢c phospholipase C (PLC)
and simultaneous acylation of the intermediate alkyl-DG. In
this study, PLC activation was followed by [3H]ethanolamine
labeling instead of [3H]myristic or [3H]octadecyl [2,3]. Thus,
we demonstrate that ET-1 activates a PLC speci¢c for alkyl-
PE and suggest that alkyl-TG generated downstream of this
novel PLC act as potent inhibitors of L-type Ca2 channels.
2. Materials and methods
2.1. Materials
Dulbecco’s modi¢ed Eagle’s medium (DMEM), fetal calf serum,
glutamine and penicillin/streptomycin were purchased from Gibco
BRL (Paisley, UK). [1-3H]Ethan-1-ol-2-amine (25 Ci/mmol) and
1-O-[3H]octadecyl-sn-glycero-3-phosphocholine (163 Ci/mmol) were
from Amersham Pharmacia Biotech (Les Ulis, France). Fura Red1/
AM and Pluronic F-127 were from Molecular Probes (Eugene, OR,
USA). Nimodipine was from Interchim (Montluc°on, France). S(3)-
BayK 8644, ET-1, ATP (magnesium salt), tricaprin (1,2,3-tridecanoyl-
glycerol), dicaprin (1,2-didecanoyl-rac-glycerol), 1-O-hexadecyl-sn-
glycerol and other chemicals were from Sigma (St. Louis, MO, USA).
2.2. Synthesis of 1-O-hexadecyl-2,3-didecanoyl-sn-glycerol
This was classically obtained by coupling decanoic anhydride to
1-O-hexadecyl-sn-glycerol in the presence of N,NP-dicyclohexylcarbo-
diimide and 4-dimethylaminopyridine (62% yield). The purity of the
synthesized product was checked [4].
2.3. Lipid metabolism in stimulated SMC
SMC were obtained from the thoracic aorta of 6-week-old pigs and
cultured as described [2]. For experiments, cells between the ¢rst and
fourth passage were seeded in 60 mm diameter dishes. After 2 days,
they were labeled for 18 h in calf serum-free DMEM supplemented
with 1 WCi/ml of [3H]ethanolamine or 1-O-[3H]hexadecyl-sn-glycero-3-
phosphocholine as previously described [2]. Cells were then incubated
with di¡erent pharmacological compounds as indicated, with or with-
out addition of ET-1 (100 nM) or various concentrations of S(3)-
BayK 8644 or A23187. Alternatively, cell stimulation was achieved by
changing the medium to DMEM containing 50 mM KCl. Reactions
were blocked by the addition of 1 ml of ice-cold methanol. Cells were
scraped and lipids extracted with the Bligh and Dyer method [5] as
already mentioned [2]. Major phospholipids and neutral lipids in the
organic phase were separated by thin-layer chromatography using two
successive runs with chloroform/methanol/acetic acid (90/10/10, v/v)
and hexane/diethyl ether/formic acid (55/45/1, v/v). Ethanolamine,
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phosphoethanolamine, and sn-glycero-3-phosphoethanolamine were
separated using methanol/2 M ammonia/0.6% NaCl (60/40/1, v/v)
as a solvent. All the spots were identi¢ed, scraped o¡ and quanti¢ed
[2].
2.4. Inositol 1,4,5-trisphosphate (InsP3) determination
Unlabeled cells were incubated as above in the presence of ET-1
and the reaction was stopped by adding 5% (w/v) trichloroacetic acid.
The InsP3 level was then determined using a kit from Amersham, the
assay being based on the competition between InsP3 generated by the
reaction and radiolabeled InsP3 from the kit according to the manu-
facturer’s instructions.
2.5. Determination of cytoplasmic free calcium concentration
([Ca2+]i)
SMC seeded on glass cover slides were incubated in a bu¡er con-
taining 137 mM NaCl, 2.7 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2,
8.4 mM HEPES and 5.6 mM glucose, pH 7.4. Cells were then incu-
bated for 45 min at 37‡C with 10 WM Fura Red acetoxymethyl ester
and 0.2% (v/v) Pluronic F-127 (Molecular Probes, Eugene, OR, USA).
Drugs were pressure-injected from an extracellular micropipette, the
tip of which was positioned in the vicinity of the recorded cells. The
concentrations reported are those in the pressure pipette. [Ca2]i
changes were routinely measured by a real-time (30 frames/s) confocal
laser scanning microscope (Odyssey XL with InterVision 1.5.1 soft-
ware, Noran Instruments Inc.). Because Fura Red is a single-wave-
length dye, its emission is a function of both intracellular Ca2 and
dye concentrations. Since £uorescence of Fura Red decreased once the
indicator bound Ca2, [Ca2]i changes were ¢rst expressed as F/Fmax
ratio. To illustrate [Ca2]i rises, the data were then plotted as F/Fmin
ratio after application of the following equation: F/Fmin = 23(F/Fmax).
3. Results
3.1. ET-1 induces the rapid activation of a PLC speci¢c for
PE closely followed by alkyl-TG production
When cells were challenged with ET-1, we observed a rapid
drop in the radioactivity of alkyl-PE with a corresponding
increase of [3H]phosphoethanolamine after 5 s (Fig. 1A). No
change was detected in the radioactivity of ethanolamine and
glycerophosphoethanolamine whose level was 100-fold lower
(not shown). Moreover (Fig. 1B), when alkyl-PE were labeled
on the alkyl backbone using 1-O-[3H]hexadecyl-sn-glycero-3-
phosphocholine as a precursor [2], the decrease in alkyl-PE
was reproduced, and a concomitant increase in alkyl-TG was
measured. Both events, release of phosphoethanolamine and
increase of alkyl-TG, were closely related (compare Fig.
1A,B). The return to baseline occurring within 30 s was the
same for the two labeling conditions. In addition, accumula-
tion of DG and phosphatidic acid occurred later and was 50-
fold lower (Fig. 1C).
Because we never observed any DG and phosphatidic acid
increase correlated with alkyl-PE decrease, it is likely that the
simplest pathway to explain the conversion of alkyl-PE into
alkyl-TG requires the removal of the phosphoethanolamine
group by a PLC and a simultaneous acylation of the inter-
mediate alkyl-DG.
Other data indicated that alkyl-PE were hydrolyzed by a
speci¢c PLC: (i) in the presence of ethanol, there was no
formation of [3H]alkyl-phosphatidylethanol, which excluded
the involvement of a phospholipase D; (ii) the transient ac-
cumulation of phosphoethanolamine was dissociated from the
generation of InsP3 by phosphoinositide-speci¢c PLC, which
peaked at 60^90 s (Fig. 1D) when compared with 5 s for
phosphoethanolamine and alkyl-TG.
Altogether these data provided strong evidence that ET-1
activates a PLC selective for alkyl-PE, the resulting alkyl-DG
being immediately acylated into alkyl-TG because they never
accumulated.
3.2. Alkyl-PE-speci¢c PLC is activated by calcium entering
SMC through L-type Ca2+ channels
We previously reported that extracellular Ca2 was abso-
lutely required for the generation of alkyl-TG induced by
ET-1 [2]. Removal of extracellular calcium also abolished
ET-1-dependent production of phosphoethanolamine, and
neither Mg2 nor Ba2 were able to restore PLC activity
(data not shown). In addition, the Ca2 ionophore A23187
(1 WM) mimicked the e¡ects of ET-1 on phosphoethanolamine
accumulation, whereas membrane depolarization induced by
50 mM KCl generated phosphoethanolamine at a level 1.6-
fold higher than ET-1 (Fig. 2A). This observation suggested
the involvement of a voltage-dependent Ca2 channel. Nimo-
dipine, a speci¢c blocker of L-type Ca2 channels [6], inhibited
ET-1-induced formation of phosphoethanolamine in SMC
Fig. 1. Time course of phosphoethanolamine (A) and alkyl-TG (B)
synthesis as evidence for alkyl-PE hydrolysis by an alkyl-PE-speci¢c
PLC after ET-1 (100 nM) activation, compared to time course of
DG and phosphatidic acid (C) and InsP3 (D) synthesis. A: Cells
were labeled with [3H]ethanolamine, stimulated with 100 nM ET-1
and the radioactivity of alkyl-PE (b) and phosphoethanolamine (8)
was determined. The right scale indicates labeling level of alkyl-PE,
while the left is for phosphoethanolamine labeling. B: Cells were la-
beled with 1-[3H]O-alkyl-sn-glycero-3-phosphocholine. The radioac-
tivity of alkyl-PE (b) and alkyl-TG (E) was determined [2]. C: Cells
were labeled with 1-[3H]O-alkyl-sn-glycero-3-phosphocholine. The
radioactivity of DG (O) and phosphatidic acid (F) was determined
[2]. D: InsP3 (a, pmol/assay) was determined as reported in Section
2. Data are means þ S.E.M. of three separate experiments each per-
formed in quadruplicate. *P6 0.05; **P6 0.01; ***P6 0.001 (Stu-
dent’s t-test).
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with an apparent IC50 of 3.4U10311 M (Fig. 2B). Moreover,
S(3)-BayK 8644, which was described as a speci¢c ‘activator’
of L-type Ca2 channels [7], was twice as e¡ective as ET-1 in
activating alkyl-PE-speci¢c PLC from SMC (Fig. 2C). This
strongly suggested that alkyl-PE-speci¢c PLC was activated
by Ca2 entering the cells through L-type Ca2 channels.
3.3. Activation of alkyl-PE-speci¢c PLC requires a pertussis
toxin-sensitive heterotrimeric G-protein
Because it was demonstrated that G-proteins can regulate
voltage-dependent Ca2 channels [8], we investigated the pos-
sible involvement of Gi or G0 heterotrimeric proteins in alkyl-
PE-speci¢c PLC regulation. As shown in Fig. 3, pretreatment
of cells with pertussis toxin abolished the accumulation of
phosphoethanolamine induced by ET-1 or BayK 8644, the
e¡ect of A23187 (1 WM) being reduced by 70%. Although
Fig. 2. Alkyl-PE-speci¢c PLC is activated via L-type Ca2 channels.
[3H]Ethanolamine-labeled cells were stimulated for 5 s with various
agents, then the reaction was blocked and the radioactivity of phos-
phoethanolamine was determined. A: Stimulation with ET-1
(100 nM), A23187 (0.1 and 1 WM), or KCl (50 mM). B: Cells were
preincubated in the absence or in the presence of various concentra-
tions of nimodipine before addition of 100 nM ET-1. C: Stimula-
tion with 100 nM ET-1 or various concentrations of BayK 8644.
Data are expressed as fold stimulation compared to non-stimulated
cells (A,C) or as percentages of the response obtained with ET-1
alone (B). They are means þ S.E.M. from three separate experiments
performed in quadruplicate. *P6 0.05; **P6 0.01; ***P6 0.001
(Student’s t-test).
Fig. 3. E¡ect of pertussis toxin on the activation of alkyl-PE-speci¢c
PLC. [3H]Ethanolamine-labeled cells were treated for 6 h in the ab-
sence (open bars) or in the presence (full bars) of pertussis toxin
(10 ng/ml), followed by stimulation for 5 s with ET-1 (100 nM),
BayK 8644 (100 nM) or A23187 (1 WM). The reaction was blocked
and the radioactivity of phosphoethanolamine was determined. Data
(means þ S.E.M. from three separate experiments performed in
quadruplicate) are percentages of the response obtained with ET-1
alone. ***P6 0.001 (Student’s t-test).
Fig. 4. Closure of L-type Ca2 channels by alkyl-TG. Variations of
[Ca2]i were determined by measuring the £uorescence of SMC
loaded with Fura Red. A: ET-1, 100 nM; B: BayK 8644, 100 nM;
C: nimodipine (1 WM, 15 min), then ET-1 (100 nM); D: nimodipine
(1 WM, 15 min), then BayK 8644 (100 nM); E: DiC10-alkyl-TG
(100 nM, 15 min), then BayK 8644 (100 nM); F: DiC10-alkyl-TG
(100 nM, 15 min), then ATP (1 mM); G: DiC10-DG (100 nM,
15 min), then BayK 8644 (100 nM); H: DiC10-DG (100 nM,
15 min), then ATP (1 mM). Each trace is representative of 14^63
determinations.
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we cannot distinguish between a direct and an indirect regu-
lation of alkyl-PE-speci¢c PLC by heterotrimeric G-proteins,
these data clearly demonstrated the involvement of a Gi or G0
protein in the activation of the PE-speci¢c PLC pathway.
3.4. Alkyl-TG inhibits both alkyl-PE-speci¢c PLC and L-type
Ca2+ channels
We synthesized diC10-alkyl-TG containing a long alkyl
chain (16 carbons) at the sn-1 position and two short acyl
chains (10 carbons) at positions 2 and 3 of glycerol, in order
to allow intercalation of the lipid in the membrane and per-
meation to the internal lea£et, as currently achieved with DG
or ceramides [9]. Preincubation of cells with diC10-alkyl-TG
for 15 min inhibited BayK 8644-induced accumulation of
phosphoethanolamine with a narrow dose^response curve.
There was no e¡ect at 1 nM, a half maximal e¡ect at 10
nM and total inhibition at 100 nM. The e¡ects of diC10-
alkyl-TG were then tested on single cells loaded with the
£uorescent Ca2 indicator Fura Red. ET-1 promoted an in-
crease in [Ca2]i which was abolished by nimodipine (Fig.
4A,C). S(3)-BayK 8644 induced a similar Ca2 in£ux and
reversed the e¡ect of nimodipine, con¢rming the presence of
functional L-type Ca2 channels in SMC (Fig. 4B,D). The
e¡ects of S(3)-BayK 8644 were abolished in cells preincu-
bated with 100 nM diC10-alkyl-TG, whereas didecanoyl-rac-
glycerol (diC10-DG) had a marginal e¡ect or even prolonged
to some extent the Ca2 signal (Fig. 4E,G). Eventually, the
increase in [Ca2]i evoked by ATP, which involves a puriner-
gic receptor acting via intracellular store Ca2 mobilization
[10,11], was insensitive to diC10-alkyl-TG (Fig. 4F), whereas
di-C10-DG produced some slight inhibition (Fig. 4H). These
data indicated that diC10-alkyl-TG was not toxic for the cells
and that its inhibitory e¡ect was probably directed against L-
type Ca2 channels.
4. Discussion
Altogether, our present data indicate that we are dealing
with a novel signaling pathway leading to the generation of a
hitherto unrecognized lipid second messenger, i.e. alkyl-TG.
In response to various agents able to elevate [Ca2] in SMC,
PE, especially alkyl species, are rapidly degraded, generating
phosphoethanolamine and alkyl-TG [2,3]. It has been shown
that platelet-activating factor was able to induce simultaneous
production of phosphocholine and phosphoethanolamine, in-
dicating that both phosphatidylcholine and PE were degraded
probably by the same enzyme [12]. Although two previous
studies suggested that some signaling pathways might involve
phosphatidylethanolamine-speci¢c phospholipases C or D
[13,14], this is the ¢rst report of an alkyl-PE-speci¢c PLC
activated very early upon cell challenge with ET-1 as an ago-
nist.
The PLC described in the present study di¡ers from previ-
ously identi¢ed enzymes by several points. First, it appears to
be selective for alkyl-PE, as shown by the lack of phosphati-
dylcholine, diacyl and alkenyl-acyl PE decrease [2]. Secondly,
this enzyme is activated very early following ET-1 stimulation,
before phosphoinositide-speci¢c phospholipase C, by a mech-
anism involving Ca2 in£ux through L-type Ca2 channels
and a pertussis toxin-sensitive heterotrimeric G-protein.
Such a dual regulation is reminiscent of the behavior of cyto-
solic phospholipase A2 [15,16]. Third, alkyl-PE-speci¢c PLC
does not lead to the accumulation of DG because of their
immediate acylation into TG. So far, we do not know which
is the fatty acyl donor involved in this secondary transacyl-
ation, i.e. acyl-CoA or a similar phospholipid.
This peculiar metabolism evoked by ET-1 in SMC led us to
consider that alkyl-TG might represent a novel lipid second
messenger. Alkyl-DG was previously reported to exert bio-
logical e¡ects similar or opposite to those of diacylglycerol
[17^20], however a speci¢c biological activity has never been
reported for triglycerides with or without a 1-O-alkyl chain.
Using short chain analogues able to cross the membrane,
we found that alkyl-TG exerted potent inhibitory e¡ects on L-
type Ca2 channels, which explains why alkyl-PE-speci¢c PLC
was also inhibited. Such an unexpected ¢nding cannot be ex-
plained by a putative degradation of TG into DG, which were
previously shown to depress L-type Ca2 channels independ-
ently of protein kinase C activation [21], for two reasons: (i)
e¡ective DG concentrations in previous studies were signi¢-
cantly higher (1^10 WM) than the concentrations of diC10-
alkyl-TG used herein (10^100 nM) which are very low com-
pared to usual agonists used; (ii) diC10-DG, under our ex-
perimental conditions, was unable to reproduce the e¡ects of
diC10-alkyl-TG (compare Fig. 4E,G). The possibility that TG
could be active via fatty acids release by a lipase is excluded as
well because fatty acids at the same concentration do not
block L-type Ca2 channels [22]. We cannot distinguish
whether alkyl-TG act directly on L-type Ca2 channels or
involve protein intermediates such as a kinase or a phospha-
tase. Protein kinase C is known to regulate the activity of L-
type Ca2 channels, but inhibition [23], activation [24] or dual
e¡ects [25] have been reported, suggesting additional mecha-
nisms of regulation by classical activators of this enzyme [21].
Moreover, acyl-TG have been shown to be inactive on protein
kinase C in vitro [20]. Further studies will be undertaken to
elucidate the mechanism of action of this novel second mes-
senger and to investigate other possible targets.
A critical question concerns the biological relevance of our
observations. Total blockade of L-type Ca2 channels was
obtained with 100 nM of di-C10-alkyl-TG which is equivalent
to 100 pmol di-C10-alkyl-TG (1 ml medium) for 12.5 nmol of
total cell phospholipids. We previously found that alkyl-PE
represent 6.75% of total phospholipids from pig aortic SMC
[2]. In other words, a 10% hydrolysis of alkyl-PE would gen-
erate 85 pmol alkyl-TG in the cell samples used in our various
experiments, basically, an amount in the same range of mag-
nitude as the di-C10-alkyl-TG added to the cells. This should
reinforce our conclusion that alkyl-TG could be considered as
a potential novel lipid second messenger. Moreover, it has to
be noted that the inhibitory e¡ect of di-C10-alkyl-TG on
L-type Ca2 channels is reversible: after 45 min incubation,
L-type Ca2 channels were no longer blocked, cells were then
able to be activated. DG was without e¡ect throughout this
time (not shown).
In addition to DG [21,23], other lipid compounds were
recently found to exert inhibitory e¡ects on L-type Ca2 chan-
nels in a very similar way to those reported here with TG.
These lipids include ceramide [26], which was e⁄cient at 10^
100 nM, and farnesol [27], which required much higher con-
centrations (1^10 WM). Finally, this conversion of PE into TG
seems not to be speci¢c of ET-1 because PDGF, which acts
via a receptor with intrinsic tyrosine kinase activity, was also
able to induce accumulation of alkyl-TG from alkyl-PE [3].
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